MARKET

DCTH

DCTH

Delcath Sys
NASDAQ
14.42
-0.33
-2.24%
After Hours: 14.42 0 0.00% 19:30 10/23 EDT
OPEN
14.73
PREV CLOSE
14.75
HIGH
14.73
LOW
14.33
VOLUME
326.48K
TURNOVER
--
52 WEEK HIGH
17.42
52 WEEK LOW
8.12
MARKET CAP
500.36M
P/E (TTM)
2363.93
1D
5D
1M
3M
1Y
5Y
1D
Delcath Systems highlights clinical program presentations at ESMO Congress 2026
TipRanks · 5d ago
Delcath Systems Presents Data Regarding Its Clinical Development Programs At European Society For Medical Oncology Congress 2026; Presents Publication Of Analysis Of Percutaneous Hepatic Perfusion With Melphalan Using CHEMOSAT Hepatic Delivery Systems
Benzinga · 5d ago
Weekly Report: what happened at DCTH last week (1012-1016)?
Weekly Report · 6d ago
BTIG Reaffirms Their Buy Rating on Delcath Systems (DCTH)
TipRanks · 10/12 13:46
Weekly Report: what happened at DCTH last week (1005-1009)?
Weekly Report · 10/12 09:15
Delcath Systems Q2 2026 Earnings Call Transcript
Benzinga · 10/06 09:31
Weekly Report: what happened at DCTH last week (0928-1002)?
Weekly Report · 10/05 09:15
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
NASDAQ · 10/01 18:39
More
About DCTH
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's proprietary products, HEPZATO KIT (HEPZATO (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP), are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATOTM KIT is a drug/device combination product. HEPZATO KIT comprises the chemotherapeutic drug melphalan and the Company’s proprietary Hepatic Delivery System (HDS). In Europe, the device-only configuration of the HDS is regulated as a Class III medical device and is approved for sale under the trade name CHEMOSAT Hepatic Delivery System for Melphalan. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA).

Webull offers Delcath Systems Inc stock information, including NASDAQ: DCTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCTH stock methods without spending real money on the virtual paper trading platform.